1994
DOI: 10.1056/nejm199401133300205
|View full text |Cite
|
Sign up to set email alerts
|

Defective Cholesterol Biosynthesis Associated with the Smith-Lemli-Opitz Syndrome

Abstract: The combination of abnormally low plasma cholesterol levels and a high concentration of the cholesterol precursor 7-dehydrocholesterol points to a major block in cholesterol biosynthesis at the step in which the C-7(8) double bond of 7-dehydrocholesterol is reduced, forming cholesterol. The block may be sufficient to deprive an embryo or fetus of cholesterol and prevent normal development, whereas the incorporation of 7-dehydrocholesterol into all membranes may interfere with proper membrane function.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

7
515
0
5

Year Published

1996
1996
2012
2012

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 764 publications
(527 citation statements)
references
References 30 publications
7
515
0
5
Order By: Relevance
“…For example, we found no similarities in the sterol pattern observed with HCV G3 to the metabolite patterns seen with enzyme dysfunction in well-characterized hereditary sterol disorders, such as 3b-hydroxysterol D 7 -reductase (Smith-Lemli-Opitz syndrome and desmosterolosis), 3b-hydroxysterol D 24 -reductase (desmosterolosis), 3b-hydroxysteroid-D 5 -desaturase (lathosterolosis), and 3b-hydroxysteroid-D 8 D 7 -isomerase (X-Linked Dominant Conradi-Hünermann syndrome; CDPX2). 21,30 Eradication of HCV G3 resulted in increased distal metabolite levels but no change in the lanosterol level, further suggesting that viral perturbation of the sterol pathway may occur at a point(s) distal from lanosterol and proximal to 7-DHC/cholesterol. Similar results were obtained when the changes before and after treatment metabolites were compared between SVR and non-SVR patients, and only postlanosterol metabolite changes differed with viral eradication.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…For example, we found no similarities in the sterol pattern observed with HCV G3 to the metabolite patterns seen with enzyme dysfunction in well-characterized hereditary sterol disorders, such as 3b-hydroxysterol D 7 -reductase (Smith-Lemli-Opitz syndrome and desmosterolosis), 3b-hydroxysterol D 24 -reductase (desmosterolosis), 3b-hydroxysteroid-D 5 -desaturase (lathosterolosis), and 3b-hydroxysteroid-D 8 D 7 -isomerase (X-Linked Dominant Conradi-Hünermann syndrome; CDPX2). 21,30 Eradication of HCV G3 resulted in increased distal metabolite levels but no change in the lanosterol level, further suggesting that viral perturbation of the sterol pathway may occur at a point(s) distal from lanosterol and proximal to 7-DHC/cholesterol. Similar results were obtained when the changes before and after treatment metabolites were compared between SVR and non-SVR patients, and only postlanosterol metabolite changes differed with viral eradication.…”
Section: Discussionmentioning
confidence: 99%
“…20 Metabolomics has been successfully used to identify hereditary sterol defects, where enzyme deficiencies perturb key processes causing elevated levels of preceding sterols and decreased downstream cholesterol synthesis. 21,22 All cholesterol synthesis must pass through the final steps of the isoprenoid metabolic pathway, which are exclusively dedicated to cholesterol synthesis (Fig. 1).…”
mentioning
confidence: 99%
“…SLO is an autosomal-recessive disorder due to mutations in the gene for D7-dehydrocholesterol reductase, 63,64 leading to increased serum levels of 7-dehydrocholesterol. The incidence has been estimated to be one in 10 000 to one in 60 000.…”
Section: Single Gene Disorders Associated With Admentioning
confidence: 99%
“…42, No. 3, 1997 biosynthesis (Tint et aL, 1994). CNS anomalies are common in Smith-Lemli-Opitz syndrome.…”
Section: Discussionmentioning
confidence: 99%